Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04395001 · ClinicalTrials.gov registry record · Phase 4
Pain Response Evaluation of a Combined Intervention to Cope Effectively
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 280
- Enrollment target
NCT04395001 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 280 participants.
The verdict
NCT04395001, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 280 participants
- Enrollment target
Study Summary
The purpose of this research is is to determine if the combination of non-opioid medication (duloxetine) and web-based pain-coping skills training (PCST) is beneficial for individuals with chronic musculoskeletal pain (CMP).
Interventions
- DRUG duloxetine
- BEHAVIORAL Web-based Cognitive Behavioral Therapy (CBT)
- OTHER Nurse-delivered Motivational Interviewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2024-07-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04395001
The ClinicalTrials.gov registry entry for NCT04395001 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which duloxetine is the first listed.
NCT04395001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04395001 about?
NCT04395001 is a clinical study titled "Pain Response Evaluation of a Combined Intervention to Cope Effectively". The purpose of this research is is to determine if the combination of non-opioid medication (duloxetine) and web-based pain-coping skills training (PCST) is beneficial for individuals with chronic musculoskeletal pain (CMP).
What is the current status of trial NCT04395001?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 280 participants. The study started on 2021-02-24. Estimated completion is 2024-07-18.
What interventions are being tested in trial NCT04395001?
The interventions under investigation include: duloxetine (DRUG), Web-based Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Nurse-delivered Motivational Interviewing (OTHER).
Who is sponsoring clinical trial NCT04395001?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.